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AbstrACt
Introduction Children and young people (CYP) in many 
high-income settings have poor healthcare outcomes, 
especially those with long-term conditions (LTCs). 
Emergency and outpatient hospital service use is 
increasing unsustainably. To address these problems, 
the Children and Young People’s Health Partnership 
(CYPHP) has developed and is evaluating an integrated 
model of care as part of a health systems strengthening 
programme across two boroughs of London, UK that are 
characterised by mixed ethnic populations and varying 
levels of deprivation. The CYPHP Evelina London model 
of care comprises proactive case-finding and triage, 
specialist clinics and transformative education and 
training for professionals working with CYP. Services 
are delivered by multidisciplinary health teams with an 
emphasis on increased coordination across primary, 
community and hospital settings and integration of 
physical and mental healthcare that accounts for the 
CYP’s social context.
Methods and analysis The phased roll out of the 
CYPHP Evelina London model allows an opportunistic 
population-based evaluation using a cluster randomised 
controlled trial design. Seventy general practices across 
two London boroughs, grouped into 23 clusters, were 
randomised to provide either the CYPHP model of care 
(n=11) or enhanced usual care (n=12). The evaluation 
will measure the impact of the CYPHP Evelina London 
model of care on child and parent health and well-being, 
healthcare quality and health service use up to 2 years 
postimplementation. A population-level evaluation will 
use routinely collected pseudonymised healthcare data 
to conduct a service-use analysis for all CYP registered 
with a participating general practice (n=~90 000) with 
the rate of non-elective admissions as the primary 
outcome. We will seek consent from a subset of this 
population, with specific conditions (target n=2138) to 
assess the impact on patient-reported outcomes using 
the Paediatric Quality of Life Inventory (PedsQL) and 
Warwick-Edinburgh Mental Well-Being Scale (WEBWMS) 
as, respectively, the child- and parent-related primary 
outcomes.
Ethics and dissemination Ethics approval obtained 
from South West-Cornwall & Plymouth Research Ethics 
strengths and limitations of this study
 ► The Children and Young People’s Health Partnership 
(CYPHP) Evelina London model of care is a new 
model of integrated, comprehensive, coordinated 
and tailored care that will be delivered to a popu-
lation catchment of over 90 000 children and young 
people across a large and diverse area of South 
London, UK.
 ► The opportunistic cluster randomised controlled trial 
design enables unique and rigorous testing of a new 
model of care, as a population-level health services 
intervention, for child health in the UK.
 ► Patient-reported and routine service use data will 
provide information on effectiveness and cost-effec-
tiveness of the CYPHP model of care on outcomes 
relating to children and young people (CYP) health 
and well-being, healthcare quality and health ser-
vices and systems.
 ► Linkage of pseudonymised health service use data 
will allow population-level impact on patterns of 
service use to be assessed.
 ► It is anticipated that not all eligible CYP will par-
ticipate in the intervention or evaluation; our 
population-based approach to case finding, and 
recruitment through a patient portal, may present 
challenges for some patients, for example, with lan-
guage, literacy or technology barriers. These factors 
mean that interventions may not reach those most in 
need. However, we will assess population-level fac-
tors, including equity, and through a robust process 
evaluation that aims to identify barriers and enablers 
to access the new model of care and gain detailed 
information about implementation.
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Committee. Results will be submitted for publication in peer-reviewed 
journals. Findings will be generalisable to community-based models of 
care, especially in urban settings. Our process evaluation will identify 
barriers and enablers of implementation and delivery of care salient to the 
context and condition.
trial registration number NCT03461848; Pre-results.
IntroduCtIon
Approximately 20% of childhood deaths across the USA, 
England, Australia and New Zealand are thought to be 
preventable through better clinical care and patient 
self-management, with higher proportions in specific 
categories such as children and young people (CYP) with 
chronic conditions.1 Between 60% and 70% of children 
who died in the UK between 2001 and 2010 had a chronic 
condition requiring frequent contact with the health 
system.2 
Chronic, non-communicable disease accounts for 79% 
of all disability-adjusted life years lost, in young people 
aged 1–14 years across Europe, with respiratory diseases 
(mainly asthma), neuropsychiatric disorders, congenital 
abnormalities and musculoskeletal disorders the predom-
inant causes of morbidity.3 This is mirrored in data from 
North America and Australia.4 5
The current model of hospital‐centred paediatric care 
in high-income countries was developed to deliver acute 
inpatient and high-intensity specialist services, rather 
than high-quality care for CYP with long-term conditions 
(LTCs) who need multidisciplinary, coordinated planned 
care to prevent illness and disease complications, and to 
maximise well-being and developmental potential.6 The 
current healthcare model, in the context of the wider 
health and social care system in the UK, has resulted in 
suboptimal health outcomes for both acute and chronic 
illness.7 8 Finally, current services are not as responsive 
to families’ needs as they should be, and are often ineffi-
cient with a reliance on high‐cost emergency department 
attendance and acute admissions.3 6 9 This is mirrored 
by inefficiencies seen in other high-income countries.10 
There is an urgent need to develop new evidence-based, 
cost-effective and sustainable healthcare services to meet 
the increasing demands caused, in part, by the rising 
prevalence of chronic illness across the life course.3 11–13
The Children and Young People’s Health Partner-
ship (CYPHP) Evelina London model was conceived in 
response to the evolving healthcare needs of CYP, and 
the dearth of evidence for health service commissioners 
and planners on how to address these needs. The CYPHP 
Evelina London model is an innovative approach to 
reshaping everyday healthcare services, expanding on the 
principles of integrated care.14 15 CYPHP Evelina London 
brings together physical and mental healthcare, and 
delivers services taking into account the social context 
of the family. It integrates primary and secondary health-
care, and links healthcare with local government efforts 
to improve the wider determinants of health. A major 
focus of the CYPHP Evelina London model is improving 
frontline care for all CYP. This is vital as primary care 
and accident and emergency departments are where the 
majority of healthcare is delivered in the UK context, 
and act as the gateway to other services. Frontline care 
can therefore be an enabler or barrier for the rest of 
the system to function well. In particular, effective and 
efficient urgent care is important to ensure that suffi-
cient resources are available for the planned, proactive, 
comprehensive care that CYP with LTC need. This eval-
uation of the CYPHP Evelina London model of care is 
designed to generate robust evidence on effectiveness 
and cost-effectiveness of an integrated model of care for 
CYP when delivered at scale to inform local, national and 
international service providers and commissioners.
Evaluation overview
The evaluation, a population-based cluster randomised 
controlled trial (cRCT) with over 90 000 CYP has four 
component parts: (1) a pseudonymised population-based 
evaluation for all CYP in participating general practices, 
(2) an evaluation of patient-reported outcomes from CYP 
with one of four specific (or ‘tracer’) conditions, (3) a 
process evaluation and (4) an economic evaluation. The 
broad evaluation aims are:
i. To evaluate the impact of the CYPHP Evelina London 
model of care on the health, healthcare and health 
service use of CYP; at the population level and for 
CYP with tracer conditions.
ii. To understand through the process evaluation how 
and why the CYPHP Evelina London model is ef-
fective or ineffective, and to identify contextually 
relevant strategies for successful implementation as 
well as practical difficulties in adoption, delivery and 
maintenance to inform wider implementation.
iii. To assess the costs of delivery and cost-effectiveness 
of the CYPHP Evelina model of care compared with 
enhanced usual care (EUC), through the economic 
evaluation.
Differences in outcomes will be compared (i) between 
practices delivering the CYPHP model compared with 
practices delivering EUC up to 2 years’ postimplementa-
tion of the service and (ii) before implementation of the 
model compared with up to 2 years after.
MEthods And AnAlysIs
study design
The implementation of the CYPHP Evelina London 
model of care across Lambeth and Southwark will occur 
in stages. This phased roll-out allows the application of an 
opportunistic cRCT, where for the first stage (lasting for 
approximately 2 years) general practices are randomised 
to either the full CYPHP Evelina London model (inter-
vention) or EUC (control). The results of this evaluation 
will inform local decision-makers about whether and/or 
how to roll out the CYPHP Evelina London model to the 
EUC general practices.
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Population evaluation
A population-level evaluation will use routinely 
collected, pseudonymised primary and secondary 
healthcare data to conduct a service use and economic 
analysis for all CYP registered with a participating 
general practice. The model will be evaluated at a popu-
lation level by comparing health service use (i) between 
CYP from the CYPHP Evelina London model and EUC 
clusters, and (ii) to historical data within the CYPHP 
Evelina London model and EUC arms (ie, before-and-
after comparison). This before-and-after analysis will 
allow us to compare the CYPHP Evelina London model 
with the healthcare offered before any enhanced care 
was introduced.
Objectives of the population evaluation are:
 ► To compare health service use (including non-elec-
tive admissions, emergency department attendance, 
outpatient appointments, general practice attend-
ances) over time, before-and-after intervention imple-
mentation and between the CYPHP Evelina London 
model and EUC practices.
 ► To examine the impact of sociodemographic determi-
nants, specifically measures of deprivation, on health 
service use over time and between the CYPHP Evelina 
London model and EUC practices.
tracer condition evaluation
A subset of the population with specific conditions 
(asthma, epilepsy, constipation, eczema) will be invited 
to consent for follow-up, as part of our tracer condition 
evaluation, to assess the impact of the CYPHP Evelina 
London model on patient-reported outcomes. These 
tracer conditions were chosen as they are examples of 
long-term and common conditions, which will provide 
generalisable lessons about improving outcomes through 
healthcare for CYP with ongoing conditions.
Objectives of the tracer condition evaluation are:
 ► To assess the impact of the CYPHP Evelina 
London model on CYP’s health-related quality of 
life (HRQOL), parent-reported disease severity, prev-
alence and severity of mental health difficulties, and 
mental well-being among parents over time, before-
and-after intervention implementation and compared 
with EUC practices.
 ► To assess the equity of service access and delivery 
(activity, costs, outcomes) across socioeconomic 
backgrounds.
Process evaluation
A nested process evaluation will explore how well the 
CYPHP Evelina London model has been implemented 
and its impact on quality of care (eg, patient/family expe-
rience, case notes audits, prescribing rates). Objectives 
relating specifically to the process evaluation and details 
of methods are presented in our accompanying process 
evaluation protocol entitled ‘The Children and Young 
People’s Health Partnership Evelina London Model of Care: 
Process Evaluation Protocol’.
Economic evaluation
We will assess the cost to the National Health Service 
(NHS) of delivering the CYPHP Evelina London model, 
cost savings in relation to any decrease in health service 
use and cost-effectiveness of the model in terms of utility 
in relation to HRQOL of CYP with tracer conditions.
Objectives of the economic evaluation are:
 ► To quantify the differences in resource use and costs 
linked to professional contacts and services deliv-
ered in managing the tracer conditions between the 
CYPHP Evelina London model and EUC.
 ► To assess secondary healthcare contacts and costs to 
the NHS.
 ► To evaluate cost-effectiveness by combining evidence 
on cost impacts and HRQOL outcomes for CYP with 
tracer conditions.
hypothesis
We hypothesise that patients from both the CYPHP Evelina 
London model and EUC practices will show improve-
ment in health outcomes between baseline and follow-up 
up to 2 years postimplementation. However, we hypoth-
esise that the impact on health outcomes will be signifi-
cantly greater in patients from CYPHP Evelina London 
practices compared with patients from EUC practices. In 
addition, we anticipate that savings attributed to service 
activity reductions at a population level will outweigh the 
costs of running the service and that the service will be 
cost-effective at the tracer condition level.
study setting
The study is being run in two inner-city boroughs of South 
London in the UK, Lambeth and Southwark. Child health 
outcomes for these two inner-city boroughs are worse in 
many instances than average in England, with high and 
rising accident and emergency attendance rates for CYP, 
emergency hospital admissions and hospital outpatient 
use.16 The CYPHP Evelina model of care components 
are being rolled out across general practices, schools and 
hospitals within Lambeth and Southwark.
Interventions
The CYPHP Evelina London model aims to provide 
comprehensive coordinated care for CYP, and tailored 
care that is responsive to patients’ needs. In practice, this 
means integrating primary and secondary healthcare, 
physical and mental healthcare, healthcare with public 
health and improving the age appropriateness of care. 
Providing tailored care that is responsive to patients’ 
needs will be achieved through roll out of several 
universal and targeted services, and through health 
system strengthening initiatives including intrasectoral 
and intersectoral partnerships, workforce training, tech-
nology and analytics. CYPHP intervention functions have 
been designed to target barriers to effective management 
of physical, mental and social determinants of health at 
both a service-provider and patient-level to maximise 
behaviour change. Further details of the underlying 
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theory and activities involved in the model of care, and 
the health needs it seeks to address, are described in our 
model of care paper.17 During phased roll out and the eval-
uation trial, the CYPHP Evelina London model comprises 
two groups: (1) interventions that are being implemented 
across both arms of the trial, called EUC and (2) the full 
CYPHP Evelina London model, comprising EUC plus 
additional interventions. Thus, EUC serves as the control 
arm, and the full CYPHP Evelina London model serves as 
the intervention arm. Services include care for CYP and 
support for parents and general practices; described in 
detail below.
Enhanced usual care (control arm)
All practices within Lambeth and Southwark will receive:
 ► Decision support tools for general practices 
comprising guidelines (in line with national evidence-
based guidelines), algorithms and referral guidance 
for common conditions such as constipation, eczema, 
urinary tract infection, enuresis, headache and food 
allergies. They are in an electronic format, embedded 
into local general practice data systems so that they 
can be accessed easily during a consultation.
 ► Paediatric hotline enabling rapid communication 
between general practices and paediatricians to 
discuss urgent support, management or referral of an 
individual child or young person.
 ► School-based emotional resilience building and 
mental health first aid.
 ► Minor illness and wellness support and services for the 
most common problems and illnesses, to help parents 
and professionals to keep CYP well at home.
 ► CYPHP Health Checks for CYP with tracer condi-
tions (asthma, epilepsy, eczema, constipation) and 
their parents—a biopsychosocial questionnaire which 
supports tailored care planning.
 ► CYPHP Health Packs for CYP and their parents, 
comprising self-management support, health promo-
tion and health education material.
Parents of patients with tracer conditions are invited to 
complete a condition-specific biopsychosocial question-
naire (CYPHP Health Check) about disease or condition 
status, emotional well-being and social factors. Invitation 
to complete the Health Check will happen by one of four 
methods. First, eligible families are identified by their 
general practice and sent a letter and text messages that 
invites them to complete an online CYPHP Health Check. 
Second, general practices and secondary care sites (eg, 
specialist clinics, outpatient departments) have paper 
copies of the Health Check available with prepaid enve-
lopes. Third, patients may self-direct to the Health Check 
web page which is promoted widely, for example, through 
schools, community events, pharmacists and social media. 
Finally, healthcare providers may directly refer patients to 
the service. Information from the CYPHP Health Check 
will be added to patients’ general practice records, and 
families will be sent a summary of their scores on the 
questionnaire and a CYPHP Health Pack.
CyPhP Evelina london model (intervention arm)
In addition to the components of the EUC arm, the 
CYPHP Evelina London model comprises two types 
of clinical services: targeted care for CYP with ongoing 
(tracer) conditions, and universal care available for CYP 
with any condition.
CYP with tracer conditions are eligible for a tailored 
clinical service delivered by the multidisciplinary CYPHP 
Health team in primary and community care settings and 
in patient’s homes. CYP and families complete a CYPHP 
Health Check which provides information for triaging 
and tailoring care. The CYPHP Health Team comprises 
specialist children’s nurses, a children’s pharmacist, 
mental health workers, associated school nurses and 
backed up by consultant paediatrician, child and adoles-
cent psychiatrist and general practice. Care includes 
health promotion, preventive and reactive care, and 
integrates services both vertically across primary and 
secondary care and horizontally between sectors.
CYP with any condition are eligible for ‘in-reach’ 
CYPHP clinics. These clinics are integrated child health 
clinics jointly run by general practices and local ‘patch 
paediatricians’ who are linked to a cluster of general 
practices. Clinics are held in primary care settings. They 
offer generalist and specialist advice co-located and coor-
dinated conveniently close to home for patients. In-reach 
clinics will typically be for CYP who would otherwise 
have been referred to hospital for an outpatient appoint-
ment with a general paediatrician. In-reach clinics also 
aim to improve clinical decision-making, provide shared 
learning opportunities and through building trust, coop-
eration and direct and virtual team-working between 
general practices and patch paediatricians, integrates 
services vertically across primary and secondary care.
The hypothesised active components of interventions 
available in each arm have been mapped against the 12 
domains of the Theoretical Domains Framework (TDF) 
to evidence the proposed mechanism through which the 
intervention becomes effective (table 1). The TDF is a 
synthesis (from across existing theories) of the different 
behavioural domains, which interventions may target to 
influence behaviour change.18 Thus, the TDF is useful for 
aiding intervention design and for process evaluations 
that aim to determine whether mechanisms of actions 
were as anticipated. While some services are available in 
both arms and are hypothesised to improve outcomes 
(eg, education and training), we hypothesise patients 
receiving the CYPHP Evelina London model will have 
significantly improved outcomes than patients receiving 
EUC by the additive behavioural domains targeted and 
the increased intensity through which domains are 
targeted due to the mode of administration. For example, 
Health Packs received in EUC target ‘motivation and 
goals’ by novel goal setting and action planning exer-
cises. However, while this material is delivered passively 
through written material in EUC, ‘motivation and goals’ 
will be targeted in patients receiving CYPHP care through 
goal-based outcome measures for children and nurses 
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Table 1 Mapping CYPHP components to the constructs of the Theoretical Domains Framework
Domain
CYPHP model of care Enhanced usual care
CYPHP care for 
tracer conditions
CYPHP ‘in-reach’ 
clinics
CYPHP 
 Health Checks for 
tracer conditions
Support tools 
and services 
for health 
professionals
Education and 
training
Knowledge: an 
awareness of 
the existence of 
something
One-to-one 
appointments where 
patients can ask 
specific questions.
One-to-one 
learning in joint 
clinics where there 
is opportunity to 
learn knowledge.
Health Packs 
describe to patients 
the causes and 
triggers of their 
condition.
Evidence-based 
guidelines, 
algorithms and 
referral guidance 
for common 
conditions 
(eg, urinary 
tract infection, 
headache, 
allergies).
Training to 
improve 
awareness of 
difficulties within 
CYP’s health to:
 ► General 
practices;
 ► Personal 
advisors;
 ► Teaching staff.
Skills: ability or 
proficiency acquired 
through practice
 ► Multidisciplinary 
working within 
health team 
fosters improved 
competence to 
tackle mental and 
social concerns 
of CYP.
 ► One-to-one visits 
with CYP helps 
improve self-
management 
skills (eg, use 
inhaler correctly).
General practices 
working with 
consultant to 
impart skills in 
managing certain 
conditions.
Health Packs 
designed to provide 
valuable skills-
based techniques in 
managing condition 
rather than simply 
provide information.
Training for:
 ► General 
practices 
on how to 
communicate 
more 
effectively with 
CYP.
 ► Personal 
advisors to 
better support 
CYP leaving 
care.
 ► Teachers on 
promoting 
emotional 
resilience in 
CYP.
Social or 
professional role and 
identity: a coherent 
set of behaviours 
and displayed 
personal qualities 
of an individual in a 
social or work setting
Multidisciplinary 
culture of health 
staff team places 
emphasis and 
responsibility on 
treating social 
and mental health 
concerns in addition 
to focusing on 
physical condition.
Beliefs about 
capabilities: 
self-efficacy or 
acceptance of 
the truth, reality 
or validity about 
an ability, talent 
or facility that a 
person can put to 
constructive use
Encouraging CYP 
and families to better 
self-manage the 
child’s condition.
Teaching other 
general practices 
how they can 
better manage a 
child’s presentation 
of illnesses.
Continued
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Domain
CYPHP model of care Enhanced usual care
CYPHP care for 
tracer conditions
CYPHP ‘in-reach’ 
clinics
CYPHP 
 Health Checks for 
tracer conditions
Support tools 
and services 
for health 
professionals
Education and 
training
Beliefs about 
consequences: 
acceptance of 
the truth, reality 
or validity about 
outcomes of a 
behaviour in a given 
situation
Routine visits 
help encourage 
positive patterns of 
behaviour and deter 
negative patterns 
of behaviour by 
providing feedback 
by health team.
Information about 
what will happen if 
CYP do not better 
manage their 
condition.
Training on the 
lasting impact 
of not treating 
CYP mental 
and physical 
health early to 
general practices, 
teachers and 
personal advisors.
Motivation and goals: 
intention or mental 
representations 
of outcomes or 
end states that an 
individual wants to 
achieve
Goal-based 
outcomes used 
routinely as part of 
clinical care to help 
encourage CYP to 
manage condition 
for a reason that is 
salient to them.
Goal setting exercises 
help CYP realise 
why managing their 
condition is relevant.
Memory attention 
and decision 
processes: the ability 
to retain information, 
focus selectively 
on aspects of the 
environment and 
choose between 
alternatives
Clinical templates 
to aid nurses to talk 
through physical, 
mental and social 
barriers for CYP not 
self-managing their 
condition effectively.
Health Pack material 
for CYP focuses 
on self-monitoring 
techniques (eg, take 
medication, plan for 
likely triggers).
 ► Clinical 
templates 
guide general 
practices on 
how to talk 
about issues 
commonly 
faced by teens.
 ► Guidelines 
advise 
appropriate 
actions.
Environmental 
context and 
resources: any 
circumstance of a 
person’s situation 
or environment 
that discourages 
or encourages the 
development of 
skills and abilities, 
independence, social 
competence and 
adaptive behaviour
CYPHP nurses are 
flexible to allow 
some patients 
home visits so that 
they can better 
understand the 
triggers for poor 
health symptoms. 
Appointments also 
longer to allow time 
for CYP to express 
their concerns.
Patients can 
receive specialist 
advice, with their 
general practice, 
within practices 
close to home 
rather than having 
to go to secondary 
or tertiary settings.
Resources 
embedded into 
local general 
practice data 
systems so 
that they can 
be accessed 
easily during 
a consultation 
to help general 
practices provide 
evidence-based 
best practice.
Social influences: 
those interpersonal 
processes that can 
cause individuals 
to change their 
thoughts, feelings or 
behaviours
CYPHP clinics 
designed to 
encourage 
interaction 
with health 
professional peers 
to gain better 
understanding of 
condition.
Table 1 Continued
Continued
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being able to talk through the material face-to-face and 
provide feedback on meeting those goals.
study eligibility criteria
For the population-level evaluation, using pseudony-
mised data, there are very broad eligibility criteria, as the 
purpose of the evaluation is to include as many CYP as 
possible. The only criteria are that the CYP is (i) <16 years 
of age at the time of service roll out and (ii) registered 
with a participating practice in Lambeth and Southwark. 
For the tracer condition evaluation, the same eligibility 
criteria as the population evaluation apply, and in addi-
tion CYP must be diagnosed or identified as having one 
or more of the four tracer conditions (constipation, 
eczema, epilepsy, asthma), express interest in the study 
when completing a CYPHP Health Check (described 
below) and give informed consent (described below).
Participants will be excluded from the evaluation if any 
of the following applies:
 ► If during the evaluation period, the patient diagnosis 
changes and a tracer condition no longer applies.
 ► If the patient is no longer registered with a partici-
pating practice (of the total 89 practices in Lambeth 
and Southwark, all are participating except 19 pilot 
practices).
 ► If the patient moves their primary residence outside 
of Lambeth or Southwark.
randomisation and blinding
As part of the implementation of the CYPHP Evelina 
London model within Lambeth and Southwark, general 
practices were grouped into virtual clusters. Where 
possible, clusters were created aligned to general practice 
Federation ‘neighbourhoods’ or other existing group-
ings. These primary care practice clusters consist of two 
to four general practices grouped together to allow the 
practices to share resources and hold ‘in-reach’ CYPHP 
clinics with a local ‘patch paediatrician’.
Of the 89 general practices within Lambeth and South-
wark, 19 practices took part in pilot testing of some 
components of the CYPHP Evelina London model of 
care. As such, these 19 practices were not randomised.
Randomisation was at the level of primary care prac-
tice cluster. Seventy general practices were grouped into 
23 clusters and were randomised to receive either the 
CYPHP Evelina London model of care (n=12) or EUC 
Domain
CYPHP model of care Enhanced usual care
CYPHP care for 
tracer conditions
CYPHP ‘in-reach’ 
clinics
CYPHP 
 Health Checks for 
tracer conditions
Support tools 
and services 
for health 
professionals
Education and 
training
Emotion: a 
complex reaction 
pattern, involving 
experiential, 
behavioural and 
physiological 
elements, by which 
the individual 
attempts to deal 
with a personally 
significant matter or 
event
CYPHP health team 
is trained to focus on 
the emotional impact 
of the condition 
and treat with equal 
emphasis as the 
physical condition.
Health Pack material 
has sections focused 
on techniques to 
manage mood and 
emotional concerns.
Clinical templates 
to guide care 
place focus on 
asking about 
any emotional 
concerns the 
CYP may be 
experiencing.
All training is 
focused on 
the emotional 
concerns of CYP.
Behavioural 
regulation: anything 
aimed at managing 
or changing 
objectively observed 
or measured actions
Clinical templates 
promote 
standardised way 
of documenting 
care delivered and 
received.
Clinical templates 
and guidelines 
provide framework 
to guide clinical 
care.
Nature of the 
behaviours: 
description of how 
the behaviour is 
conducted
Documented 
procedures on 
how to manage the 
physical, social and 
emotional concerns 
of CYP.
Behaviours 
taught through 
collaborative 
clinics will be 
taken by general 
practices to use in 
regular practice.
Visual information 
on how to conduct 
positive self-
management 
behaviours.
Guidance on 
appropriate 
behaviours to 
follow in providing 
support.
Training to 
discourage 
maladaptive 
behaviours 
and foster new 
patterns.
Green, active delivery (eg, face-to-face, guided demonstration).
Yellow, passive delivery (eg, written text, leaflet).
CYPHP, Children and Young People’s Health Partnership ; CYP, children and young people.
Table 1 Continued
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(n=11). Clusters were initially stratified by borough. A 
restricted randomisation was then carried out on the 23 
clusters. Restriction ensured minimal difference between 
intervention and control arms with regard to:
 ► Baseline Index of Multiple Deprivation (IMD): differ-
ence in mean IMD score <2.5 (mean IMD 30, range of 
IMD mean score by cluster 20–37).
 ► Income Deprivation Affecting Children Index 
(IDACI): difference in mean IDACI <2.5 (mean 
IDACI 29, range 17–37).
 ► CYP population under-16 per general practice cluster: 
difference in mean population <1000 (mean under-16 
population 3914, range 2951–5674).
 ► Outpatient (OP) clinic referrals: difference in mean 
number of referrals <100 (mean number of OP 
referral 373, range 256–505).
We generated 56 580 unique randomisations which met 
the restriction criteria. We checked that cluster pairs were 
not always grouped together. From these 56 580 randomi-
sations we selected one at random.
The evaluation will not be blinded at the level of the 
service delivery or participant. Study personnel are 
blinded to allocation at the time of recruitment and 
assessment. Stages of identification, recruitment, rando-
misation and assessment are highlighted in figure 1 using 
a cluster trial timeline diagram.19
recruitment and consent
For the population evaluation, data sharing agreements 
have been established for access to pseudonymised data 
for all CYP across the two boroughs. Individual-level 
recruitment and consent is not required for the popula-
tion evaluation since administrative data are provided to 
the research team in pseudonymised form. The data are 
termed pseudonymised as it is only identifiable by a third 
party (data custodian) who has access to the ‘pseudony-
misation key’ which allows record linkage.
For the tracer condition evaluation, at completion of 
the Health Check, parents of CYP with a tracer condition 
will be provided with written information for both the 
Figure 1 Timeline of cluster randomised controlled trial process. CYPHP, Children and Young People’s Health Partnership.
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parent and CYP about the evaluation and invited to partic-
ipate in the evaluation. The informed consent process 
to participate in the evaluation and follow-up can take 
place through the web-based portal, in person, or by post. 
Parents will be asked to: (i) provide informed consent for 
the evaluation team to access their child’s clinical details 
including Health Check information, and have access 
to, and link, the child’s general practice and hospital 
data to assess the impact of CYPHP on both primary and 
secondary health service use, (ii) complete an evaluation 
questionnaire at baseline (including health-related quality 
of life measured by Paediatric  Quality of Life Inventory 
(PedsQL) and Child  Health Utility 9D (CHU-9D), and 
parental well-being measured by the Warwick-Edinburgh 
Mental Well-Being Scale (WEMWBS)) and (iii) give 
informed consent to be contacted to participate in qual-
itative studies evaluating the service. Information sheets 
will make it clear that parents can consent or refuse 
consent to any of these components. Participants will be 
free to withdraw consent without prejudice at any time. 
A parent/carer alone or with their child may be involved 
in the recruitment process. If the CYP is under 12 years 
of age the parent/carer will be asked to provide, on 
behalf of the child, informed consent, if they are happy 
to take part in the evaluation. If the CYP is between 12 
and 16 years of age, the parent will be asked to provide 
informed consent and if the CYP is available at the time 
when parental consent is requested, the CYP will be asked 
to provide assent if they wish to participate. Question-
naire data for patients with epilepsy is not eligible for 
the primary comparison between intervention and EUC 
practices because these patients are primarily managed 
under secondary care and are found through a different 
case finding procedure. As such, their experiences of 
the CYPHP Evelina model of care may be different than 
the other three conditions. However, their questionnaire 
data will be used for a before-and-after, epilepsy-specific 
comparison and they are still included in the process eval-
uation so that we can understand their experience of care 
(figure 2). To compensate parents/carers for their time in 
completing the questionnaires, they will be provided with 
a £5 gift voucher on completion of the baseline and final 
follow-up assessments. In addition, following completion 
of the second assessment, participants will be enrolled 
into a draw for a tablet computer. Details of recruitment 
of participants for the process evaluation are outlined in 
the accompanying paper entitled ‘The Children and Young 
People’s Health Partnership (CYPHP) Evelina London Model of 
Care: Process Evaluation Protocol’.
Follow-up
Participants who consent to take part in the tracer condi-
tion evaluation will be followed up for 2 years and will be 
asked to complete two questionnaires about the health 
of their child during the follow-up period. Questionnaire 
completion may occur up to 4 months after the end of the 
follow-up period.
outcomes
Outcome measures include parent-reported child 
health, health service use and economic impact. Process 
outcomes, including quality of care, are described in 
the accompanying process evaluation protocol entitled 
‘The Children and Young People’s Health Partnership Evelina 
London Model of Care: Process Evaluation Protocol’. The 
methods to assess outcomes are both quantitative and 
qualitative. ‘Self’-reported outcomes collected include 
parent-reported and child-related, and parent-related 
and child self-reported outcomes, where appropriate. 
Self-reported outcomes will be completed at baseline 
and up to 2 years’ postimplementation of the service. For 
all outcomes, differences in outcomes will be compared 
between practices delivering the CYPHP Evelina London 
model compared with practices delivering EUC, up to 
2 years’ postimplementation of the service. In addition, 
the impact of the CYPHP Evelina London model will be 
assessed by comparing outcomes before implementation 
of the model compared with up to 2 years after.
Population evaluation outcomes
The primary outcome of the population evaluation is 
the difference in the rate of non-elective hospital admis-
sions (count per patient-year) among CYP from practices 
delivering the CYPHP Evelina London model compared 
with practices delivering EUC. Secondary outcomes of 
the population evaluation will be rates of primary and 
secondary health service use, including general prac-
tice attendances, emergency department attendance, 
outpatient appointment referrals, outpatient appoint-
ment attendances, ambulatory care sensitive admissions, 
proportion of non-elective admissions that are ambu-
latory care sensitive and rate (sum per patient-year) of 
non-elective admissions and outpatient appointment 
referrals, combined. Box 1 lists the indicators of health-
care use that will be measured using routinely collected 
health services data, in pseudonymised format.
tracer condition evaluation outcomes
The primary outcome measure of the tracer condition 
evaluation is HRQOL, as measured by PedsQL.20 The 
PedsQL is a brief, standardised, generic assessment 
instrument that systematically assesses patients’ and 
parents’ perceptions of HRQOL in paediatric patients. 
The PedsQL is based on a modular approach to measure 
HRQOL and consists of a 15-item core measure of global 
HRQOL and 8 supplemental modules assessing specific 
symptom or treatment domains. The survey integrates 
generic core scales and disease-specific modules.
Secondary outcomes of the tracer condition evaluation 
include health service use, physical condition symptom 
severity, mental health and parental well-being. Health 
service use will be analysed using individual data with 
consent, and aggregate pseudonymised data. Consent will 
be requested to link patient-level primary and secondary 
healthcare use data to analyse the impact of the CYPHP 
Evelina London model on both primary and secondary 
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health service use. In addition, pseudonymised data on 
healthcare use will be aggregated for all CYP with tracer 
conditions allowing analysis of the impact of the model on 
all patients in this population. A further benefit in using 
pseudonymised data is that it will help to characterise 
(but not identify) patients who declined to participate, 
or did not engage. This will identify distributional equity 
issues by examining the differential impact on costs and 
outcomes for different patient and social groupings.
Physical condition symptom severity, mental health and 
parental well-being will be analysed using data derived 
from the CYPHP Health Check questionnaires which 
are used by clinicians for biopsychosocial assessment and 
tailoring care, and if consent is given data will also be 
used for evaluation (table 2). The CYPHP Health Check 
includes a condition-specific disease severity question-
naire for each of the four tracer conditions, the Strengths 
and Difficulties Questionnaire (SDQ) to measure mental 
Figure 2 Diagram of patients, services and levels of the evaluation. CYPHP, Children and Young People’s Health Partnership; 
CYP, children and young people; QALY, quality-adjusted life year.
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health, and a bespoke measure of social conditions (eg, 
parental mental health, social deprivation). The SDQ 
is completed as part of the Health Check to provide an 
estimate of the prevalence and severity of mental health 
difficulties of CYP with tracer conditions, as measurement 
of mental health is not routinely collected by (physical) 
health services within the UK. Scores on the SDQ is being 
used as part of clinical practice to assess child mental 
health symptoms and help tailor care specific to need.21 
The SDQ is a standardised screening questionnaire used 
extensively in mental health research with young people.22 
The SDQ consists of 25 questions arranged to create four 
subscales (measuring emotional symptoms, conduct, 
hyperactivity and inattention and peer relationship diffi-
culties). The impact supplement will also be completed. 
A version can be completed by the parent/carer for CYP 
aged 2–17 years. The Asthma Control Test (ACT) is being 
used to assess severity of physical symptoms in patients 
with asthma. The ACT is a self-report measure designed 
for adults and adolescents 12 years or older.23 The Child-
hood ACT is used for CYP aged 4–11 years. The ACT has 
five items asking about patients’ symptoms over the past 
4 weeks, which are each scored on a 5-point scale. The 
Childhood ACT has seven items which use a 5-point scale 
but where four questions are answered by the child and 
three questions are answered by the parent/carer using 
the same 4 weeks’ reference frame. Patients with eczema 
(or their parents/carers) complete the Patient-Oriented 
Eczema Measure (POEM).24 The POEM is a tool used 
for monitoring atopic eczema severity. It focuses on the 
illness as experienced by the patient. The scale includes 
seven items with a 1-week reference frame, and produces 
a score (0–28) and severity level (‘clear or almost clear’ 
to ‘very severe eczema’). Patients with constipation and/
or epilepsy (or their parents/carers) will be asked to 
complete bespoke condition-specific measures created 
for the purposes of the clinical service. Measures were 
created by CYPHP clinicians and researchers based on 
National Institute for Health and Care Excellence guide-
lines and clinical utility.
Additional measures, for evaluation only, are asked 
of parents/carers who have given their consent. The 
CHU-9D is a generic measure of quality of life that can be 
applied to paediatric populations.25 The measure consists 
of items with preference weights that give utility values 
for each health state described, allowing the calculation 
of QALYs for use in cost utility analysis. The scale has nine 
dimensions and each item is scored on a 5-point scale. 
The WEMWBS is a 14-item scale of mental well-being, 
validated for adults. WEMWBS covers subjective well-
being and psychological functioning, in which all items 
Table 2 Tracer condition outcome measures used as part 
of clinical service and study evaluation
Domain measured Outcome measure
Self-report measures used for clinical service and 
evaluation (CYPHP Health Check)
Asthma severity Asthma Control Test
Eczema severity Patient-Oriented Eczema 
Measure
Constipation severity Bristol Stool Chart
Bespoke constipation 
questionnaire
Epilepsy severity Bespoke epilepsy 
questionnaire
Mental health concerns Strengths and Difficulties 
Questionnaire
Social context Bespoke social screen 
questionnaire
 ► Social deprivation (three 
items)
 ► Parent mental health (one 
item)
 ► Employment (one item)
 ► Ethnicity (one item)
Self-report measures used for evaluation
Primary outcome: health-
related quality of life
Paediatric Quality of Life 
Inventory
Economic data on child 
quality of life
Child Health Utility 9D
Parental well-being Warwick-Edinburgh Mental 
Well-Being Scale
Health service use (individual-level data linked with 
consent)
Rate of non-elective admissions
General practice attendances
Emergency department attendances
Outpatient appointment referrals
Outpatient appointment attendances
Ambulatory care sensitive admissions
Proportion of non-elective admissions that are ambulatory 
care sensitive
Rate (sum per patient-year) of non-elective admissions and 
outpatient appointment referrals 
CYPHP, Children and Young People’s Health Partnership. 
box 1 Population evaluation outcome measures
Primary outcome:
 ► Rate of non-elective admissions.
secondary outcomes:
 ► General practice attendances.
 ► Emergency department attendances.
 ► Outpatient appointment referrals.
 ► Outpatient appointment attendances.
 ► Ambulatory care sensitive admissions.
 ► Proportion of non-elective admissions that are ambulatory care 
sensitive.
 ► Rate (sum per patient-year) of non-elective admissions and outpa-
tient appointment referrals.
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are worded positively and address aspects of positive 
mental health.26
The economic evaluation includes assessment of 
implementation, and primary care and hospital services, 
primarily from the NHS perspective. Implementation 
inputs will be measured through activity logs used to 
record time, equipment and building space and costed 
using national and locally relevant unit costs. Resource 
use and costs of services delivered in primary care will be 
evaluated through use of CYP contact data with specific 
professionals and services delivered within primary care 
settings, combined with national and locally relevant 
unit costs. Hospital-based service contacts will be iden-
tified through linkage between primary care and HES 
data systems. Appropriate national and local unit costs 
estimates will be applied to cost hospital service contacts. 
Quality-adjusted life year (QALY) outcomes relating to 
acute and non-acute impacts on CYP health and quality 
of life will be estimated from the CHU-9D measure.
Patient and public involvement
The CYPHP Evelina London model was developed 
with key stakeholders including CYP, carers, frontline 
practitioners and providers and health service commis-
sioners. Stakeholders were involved in the development 
of the theoretical framework for CYPHP, identification 
of research questions and refining the research meth-
odology. A specific CYPHP patient and public involve-
ment group was developed with CYP and their families 
and allowed us to consult with regard to all aspects of the 
evaluation design; including appropriateness of outcome 
measures, consent procedures and self-management 
material that was developed as part of EUC.
sample size calculation
For the population evaluation, pseudonymised data from 
all CYP (<16 years) within participating practices will be 
used to analyse the impact of the CYPHP Evelina London 
model on health service use. Eleven clusters in each arm, 
and an average of 3800 CYP per cluster, provides over 
87% power to detect a reduction of 20% in the rate of 
non-elective admissions, assuming a coefficient of vari-
ation of 0.142, and baseline rate of 56 admissions per 
1000 person-years. The number of CYP per cluster is 
estimated conservatively based on the 89 382 CYP (age 
0–15 years) registered in 2015 in the general practices in 
the 23 randomised clusters. The baseline rate of non-elec-
tive admissions and the coefficient of variation were esti-
mated using counts of non-elective admissions per cluster 
from financial years 2013–14 to 2015–16, and counts of 
CYP enrolled per cluster during 2013–15. The coefficient 
of variation used in the sample size calculation was the 
mean of these three estimates. The rate of non-elective 
admissions was the total rate estimated by combining data 
from the three financial years 2013–16.
For the tracer condition evaluation, we hypothesise that 
the intervention will have an effect on both infant health 
and parent health but we believe that the mechanisms 
may be theoretically different and we believe that parental 
well-being may be a potential mediator. Therefore, we 
have included both a child-based and parent-based 
health outcome in our sample size calculations. With 11 
clusters in each study arm, the study team will need to 
recruit a minimum of 1068 CYP with a tracer condition 
(asthma, constipation or eczema) per arm (total 2138) 
(see ‘Recruitment and consent’ section for rationale why 
epilepsy not included in sample size calculation). This 
number of participants will give the study 90% power to 
detect a mean minimum clinically important difference 
(MCID) of 4.5 points (SD 16.5) in the primary outcome 
tool for child HRQOL (parental-reported PedsQL),20 as 
used previously with CYP with chronic health conditions 
such as asthma.27 The intraclass correlation coefficient 
(ICC) is assumed to be 0.02 based on a study of quality 
of life in CYP with a related condition, hay fever.28 The 
between-cluster coefficient of variation in cluster size is 
assumed to be 0.03 based on the harmonic mean and vari-
ance of cluster size derived from general practice regis-
trations. The recruitment target also accounts for a 30% 
loss to follow-up. In total, there are 23 clusters, 12 in one 
arm and 11 in the other; as such the outlined sample size 
underestimates the total power as we have assumed 11 
clusters in each arm. This same sample size provides over 
90% power to detect a mean MCID of 3 points (SD 8.4) 
in the parental primary outcome tool, WEMWBS.26 Here, 
the ICC is assumed to be 0.03, based on pilot data from 
the Wellbeing in Secondary Education (WISE) trial.29 
Again, this allows for 30% loss to follow-up.
data analysis and reporting
A detailed analysis plan will be finalised before receipt 
of study data. Findings will be reported according to the 
Consolidated Standards of Reporting Trials guidelines 
for cRCTs. Flow charts will show the numbers of clusters, 
the numbers of CYP recruited and followed up to each 
time point post recruitment. Balance between CYPHP 
Evelina London and EUC clusters will be presented for a 
predefined set of potential confounding factors, and anal-
yses adjusted for any major imbalances. All analyses will 
take into account the cluster design.30 Summary values 
(of each outcome) will be presented for each cluster, and 
for CYPHP Evelina London and EUC groups compared 
using t-test and Χ2 test for continuous outcomes and 
binary outcomes, respectively.
Random-effects regression analyses using individu-
al-level data will be used to simultaneously adjust for the 
clustered design and any imbalances between CYPHP 
Evelina London and EUC arms; logistic regression 
models will be used for binary outcomes, Poisson regres-
sion for rates (eg, admission rates) and linear regression 
for continuous outcomes (eg, PedsQL scores). Effect 
sizes will be presented as ORs for binary outcomes, rate 
ratios for rates and as mean differences for continuous 
outcomes; 95% CIs will also be given. Regression analyses 
will also be used to assess whether the impact of the inter-
vention differs by wealth quintile.
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Primary analyses will be intention-to-treat and include 
all data from participants regardless of their exposure to 
intervention activities. Per-protocol analyses will also be 
carried out to examine the impact of the intervention 
taking into account engagement with the respective clin-
ical services of the universal EUC services and services 
specific to patients with tracer condition.
EthICs And dIssEMInAtIon
We plan to use the Method for Aggregating the Reporting 
of Interventions in Complex Studies31 approach to bring 
together complex data from multiple sources to evaluate 
this complex intervention. Results will be disseminated 
through publication in peer-reviewed articles, through 
presentation at national and international meetings, 
and via websites including CYPHP programme, partners, 
funder and sponsor. Results, including a lay summary, will 
be shared with participants through publicly accessible 
websites, and participants who gave consent will receive 
information about their contribution to the evaluation. 
Participant identifiable data will be removed from all 
publications.
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